# Sequential Treatment of Extra-Corporeal Shock Wave Combined With aUtologous Bone marRow Mesenchymal Stem Cells on Patients With ischEmic Heart Disease : the S-CURE Study

> **NCT03397095** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Shanghai 10th People's Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Ischemic Heart Disease

## Interventions

- **COMBINATION_PRODUCT:** CSWT+BMMSCs
- **DEVICE:** CSWT+Sham operation

## Key facts

- **NCT ID:** NCT03397095
- **Lead sponsor:** Shanghai 10th People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-04-03
- **Primary completion:** 2019-12-01
- **Final completion:** 2022-04-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2019-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03397095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03397095, "Sequential Treatment of Extra-Corporeal Shock Wave Combined With aUtologous Bone marRow Mesenchymal Stem Cells on Patients With ischEmic Heart Disease : the S-CURE Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03397095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*